Cosmetic & skin
Leuphasyl (pentapeptide-18)
Also called Pentapeptide-18, [D-Ala2]-Leu-enkephalin, H-Tyr-D-Ala-Gly-Phe-Leu-OH, YaGFL
Leuphasyl is the trade name of pentapeptide-18, a small lab-made peptide used in anti-wrinkle creams and serums. It is modeled on enkephalins, natural nerve-signaling peptides, and is often described as a 'Botox-like' ingredient you rub on instead of inject. Human evidence is very thin: there is no controlled study of the peptide on its own, and the few published skin studies either give no results in their abstract or tested it mixed with retinol.
New · under editorial review. Added October 30, 2026 by our automated research, with every claim sourced. A person has not checked this page yet; treat it with extra care. How we research
Overview
Leuphasyl is the trade name of pentapeptide-18, a small lab-made peptide used in anti-wrinkle creams and serums. It is modeled on enkephalins, natural nerve-signaling peptides, and is often described as a 'Botox-like' ingredient you rub on instead of inject. Human evidence is very thin: there is no controlled study of the peptide on its own, and the few published skin studies either give no results in their abstract or tested it mixed with retinol.
How it works
Proposed, not shown in human skin: authors describe pentapeptide-18 as acting like an enkephalin. It is said to bind enkephalin receptors on nerve cells at the nerve-muscle junction, which would reduce the release of the signal chemical acetylcholine and so relax the small facial muscles that form expression lines 23. These statements in the papers are not backed by their own experiments, and a 2020 review cites the manufacturer's own documents, not peer-reviewed studies, for some supporting claims (such as a boost when combined with Argireline) 5. Whether enough of the peptide passes through the skin to reach those nerve endings has not been shown in the sources reviewed.
What research shows
- Human cosmetic study (Romania, 2014): creams with 0.5%, 1% or 2% Leuphasyl were applied over the brow and eye-area muscles, and frown-line changes were measured with an imaging device. The abstract does not report results, group size or whether there was a control group, and the full text could not be opened for this review 2.
- Combination study (Poland, 2024; 20 women aged 30–65, 8 weeks): each volunteer used an eye cream with retinol plus pentapeptide-18 in lipid nanoparticles and a base cream without these actives. Total wrinkle area fell 20% vs 11% with the base cream. There was no placebo group, randomization or blinding was not described, and the peptide's own effect cannot be separated from retinol's 3.
- Combination study (Poland, 2024; an anti-aging group of 20 women, 8 weeks; a second group of 20 tested anti-acne creams): a night cream with retinol plus pentapeptide-18 nanoparticles cut wrinkle counts by 29% on the forehead and 18% around the eyes vs 6% and 9% with the base cream. Again no placebo group, no blinding described, and retinol was present 4.
- Lab studies: pentapeptide-18 showed no toxicity to cultured human skin cells (HaCaT) up to 1 mg/mL, and computer models suggested it may bind skin-aging enzymes such as MMP-13; these are not human results 7.
- Cell study: versions of pentapeptide-18 with an added D-tyrosine reduced melanin in pigment cells and a 3D skin model; this tested modified peptides, not Leuphasyl itself 6.
- A 2026 systematic review (published as a letter) of topical 'Botox-like' peptides for wrinkles included 11 studies, mostly of acetyl hexapeptide-8 (Argireline); none tested Leuphasyl 12.
Doses studied in people
| Study or label | Dose used | Source |
|---|---|---|
| Human cosmetic study (2014; abstract only, group size not reported), topical cream — product concentration, not a dose | Emulsions containing 0.5%, 1% or 2% Leuphasyl applied to the skin over the brow and eye-area muscles | 2 |
Leuphasyl is only used on the skin. The figures shown are cream concentrations from one published study, reported only from its abstract and not recommended; there are no human studies of injected or oral use.
Read this first: these are the amounts given to participants in published studies or written on official prescribing labels, reported for reference. They are not recommendations. Trial doses were chosen for specific patients under medical supervision, and a dose that is safe in one person can be harmful in another.
Vial math
Many research vials hold 5 or 10 mg of powder. This table shows how much ends up in each mark on a U-100 insulin syringe for common amounts of added liquid. It is arithmetic only, not a dose.
| Vial | Liquid added | Concentration | Per unit (0.01 mL) | |
|---|---|---|---|---|
| 5 mg | 1 mL | 5 mg/mL | 50 mcg | Open in calculator |
| 5 mg | 2 mL | 2.5 mg/mL | 25 mcg | Open in calculator |
| 5 mg | 3 mL | 1.67 mg/mL | 16.7 mcg | Open in calculator |
| 10 mg | 1 mL | 10 mg/mL | 100 mcg | Open in calculator |
| 10 mg | 2 mL | 5 mg/mL | 50 mcg | Open in calculator |
| 10 mg | 3 mL | 3.33 mg/mL | 33.3 mcg | Open in calculator |
More sizes: all vial sizes · How this works: Syringes and units · Reconstitution guide.
Safety
- The two 2024 volunteer studies asked participants to report any adverse effects, but neither paper presents adverse-event results, so tolerability of the peptide is not documented 34.
- In lab tests it did not harm cultured human skin cells at concentrations up to 1 mg/mL 7.
- Pentapeptide-18 is chemically the same as [D-Ala2]-Leu-enkephalin, a laboratory enkephalin analog 1. Its effects if absorbed into the body have not been studied in the cosmetic sources reviewed.
- Long-term safety of daily use is unknown; the 2024 volunteer studies lasted 8 weeks 34.
Report side effects of any drug or product to the FDA through MedWatch. For a possible poisoning in the US, call Poison Control at 1-800-222-1222.
Legal status
- FDA
- Not an FDA-approved drug. In the US it is used as a cosmetic ingredient; FDA does not approve cosmetics or their ingredients (other than color additives) before sale 8. FDA says products that claim to change skin structure, such as removing wrinkles, are drugs rather than cosmetics 9.
- Compounding
- Not named on FDA's 503A bulk drug substance category lists (updated May 14, 2026) 10.
- Sports (WADA)
- Not named on the WADA 2026 Prohibited List 11.
- Other
- EU cosmetic (CosIng) and Cosmetic Ingredient Review status could not be verified from a primary source in this review.
Rules change often. See Legal status of peptides for how these categories work.
History
Leuphasyl was developed as a cosmetic ingredient by the Spanish company Lipotec; a 2020 review cites a 2005 Lipotec document for it and notes that the synergy claims with Argireline come from the maker 5. The first peer-reviewed human study we found was a Romanian study published in 2014 that tested creams with 0.5%, 1% and 2% Leuphasyl; only its abstract could be checked, and it gives no group size or results 2. Later papers (2020–2026) have mainly been lab, cell and computer-modeling studies, plus two 2024 Polish volunteer studies of creams that combined it with retinol 3467.
Common questions
What is Leuphasyl?
Does Leuphasyl work like Botox?
What does the human evidence show?
Is Leuphasyl FDA-approved?
Is it safe?
Is Leuphasyl banned in sport?
It is not named on the WADA 2026 Prohibited List 11.
Related compounds
Argireline (acetyl hexapeptide-8)
acetyl hexapeptide-8 · acetyl hexapeptide-3 (older INCI name)
Argireline is a short lab-made peptide used in anti-wrinkle creams and serums.
SNAP-8 (acetyl octapeptide-3)
Acetyl octapeptide-3 · Acetyl glutamyl heptapeptide-3
SNAP-8 is a short lab-made peptide used in anti-wrinkle creams and serums.
Palmitoyl pentapeptide-4 (Matrixyl)
Matrixyl · Pal-KTTKS
Palmitoyl pentapeptide-4, sold under the trade name Matrixyl, is a skin-care ingredient made of five amino acids joined to a fatty acid.
GHK-Cu
Copper tripeptide-1 · Copper peptide
GHK-Cu is a tiny three-amino-acid peptide (GHK) bound to copper.
Sources
- PubChem: Pentapeptide-18 (CID 10099522) — formula, molecular weight, synonyms and CAS Database
- Dragomirescu AO et al. The Efficiency and Safety of Leuphasyl—A Botox-Like Peptide. Cosmetics 2014;1(2):75–81 (abstract) Journal
- Pawłowska M et al. Solid Lipid Nanoparticles Incorporated with Retinol and Pentapeptide-18—Optimization, Characterization, and Cosmetic Application. Int J Mol Sci 2024 (PMID 39337562) Journal
- Pawłowska M et al. Retinol and Oligopeptide-Loaded Lipid Nanocarriers as Effective Raw Material in Anti-Acne and Anti-Aging Therapies. Life (Basel) 2024 (PMID 39459512) Journal
- Errante F et al. Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy. Front Chem 2020 (PMID 33195061) PubMed review
- Park J et al. D-tyrosine adds an anti-melanogenic effect to cosmetic peptides. Sci Rep 2020 (PMID 31937863) Journal
- Akhan D et al. Integrative In Silico and In Vitro Evaluation of Vialox and Leuphasyl Pentapeptides for Antiaging Applications. Chem Biodivers 2026 (PMID 42116636) Journal
- FDA: Is it a cosmetic, a drug, or both? (or is it soap?) Regulatory
- FDA: Wrinkle treatments and other anti-aging products Regulatory
- FDA: Bulk drug substances nominated for use in compounding under section 503A (categories list, updated May 14, 2026) Regulatory
- WADA 2026 Prohibited List, International Standard (full text, federation-hosted copy) Regulatory
- Aung PZ, Nararatwanchai T. NoTox Tweakments: Evidence for Topical Neurocosmetic Peptides as Needle-Free Neuromodulators for Facial Wrinkle Reduction—A Systematic Review. J Cosmet Dermatol 2026;25(9):e71137 (letter; no PMID at time of check) Journal
Wondering how to judge the claims made about compounds like this one? The Academy track Thinking clearly about peptide claims walks through it. You can try the Academy free first.
Last reviewed 2026-10-30 · How we research · Found an error? See our corrections policy.